Literature DB >> 6148999

Anticonvulsant action of amino acid antagonists against kindled hippocampal seizures.

D W Peterson, J F Collins, H F Bradford.   

Abstract

Electrical stimulation of the ventral hippocampus 5 times daily produced significant seizure activity (stage 4), but further stimulations seldom produced full motor seizures (stage 5). Blockade of these seizures with amino acid antagonists, phosphonocarboxylic acids, was achieved but with a reverse order of potency to that seen with the kindled amygdala. Thus APB was the most potent and APH the least potent analog tested. These results indicate that the kindling of different limbic brain areas may involve different neuronal substrates even if the development of the seizure activities are similar.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6148999     DOI: 10.1016/0006-8993(84)91414-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  5 in total

1.  Spider toxin (JSTX-3) inhibits the convulsions induced by glutamate agonists.

Authors:  T Himi; H Saito; N Kawai; T Nakajima
Journal:  J Neural Transm Gen Sect       Date:  1990

Review 2.  Selective vulnerability of brain: new insights from the excitatory synapse.

Authors:  R C Collins
Journal:  Metab Brain Dis       Date:  1986-12       Impact factor: 3.584

3.  The postsynaptic density: a possible role in long-lasting effects in the central nervous system.

Authors:  P Siekevitz
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

4.  Effect of septal kindling on glutamate binding and calcium/calmodulin-dependent phosphorylation in a postsynaptic density fraction isolated from rat cerebral cortex.

Authors:  K Wu; C Wasterlain; L Sachs; P Siekevitz
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

5.  Competitive NMDA receptor antagonists raise electrically kindled generalized seizure thresholds.

Authors:  M J Croucher; K L Cotterell; H F Bradford
Journal:  Neurochem Res       Date:  1992-05       Impact factor: 3.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.